The Novo Group has acquired Xellia Pharmaceuticals for about $700 million. The sellers are 3i and other Xellia shareholders. Xellia, of Oslo, Norway, is a specialty pharmaceutical company focused on anti-infective products.
EQT-backed Sagility acquires clinical documentation and coding firm Chirok Health
23 October 2026 · 1 min read
Blue Sea Capital-backed One Physics adds two West Coast medical physics firms
23 October 2026 · 1 min read
AEA Investors-backed American Oncology Network inks $2.4bn sale to Cencora
23 October 2026 · 2 mins read
Warburg Pincus-backed Appasamy acquires German ophthalmic surgery firm Ruck
23 October 2026 · 1 min read
New Harbor Capital’s LGM Pharma acquires contract lab Sannova Analytical
23 October 2026 · 2 mins read
Amulet-backed TFP Fertility acquires Manchester Fertility Group in UK add-on
23 October 2026 · 1 min read
Rubicon Technology Partners’ Procede Software acquires dealer software firm RIMSS
23 October 2026 · 2 mins read
